ES2964230B2 - Derivados N-((9-cloro-3,4-dihidro-2H-benzo[b][1,4]dioxepin-7-il)metil)-2-(6-fluoro-1H-indol-3-il)etano-1-amina, su modo de obtencion y su utilizacion - Google Patents

Derivados N-((9-cloro-3,4-dihidro-2H-benzo[b][1,4]dioxepin-7-il)metil)-2-(6-fluoro-1H-indol-3-il)etano-1-amina, su modo de obtencion y su utilizacion Download PDF

Info

Publication number
ES2964230B2
ES2964230B2 ES202330969A ES202330969A ES2964230B2 ES 2964230 B2 ES2964230 B2 ES 2964230B2 ES 202330969 A ES202330969 A ES 202330969A ES 202330969 A ES202330969 A ES 202330969A ES 2964230 B2 ES2964230 B2 ES 2964230B2
Authority
ES
Spain
Prior art keywords
benzo
dihydro
chloro
dioxepin
indol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES202330969A
Other languages
English (en)
Spanish (es)
Other versions
ES2964230A1 (es
Inventor
Agnieszka A Kaczor
Tomasz M Wrobel
Agnieszka Grudzinska
Agata Zieba
Piotr Stepnicki
Dariusz Matosiuk
Perez Maria De Los Angeles Castro
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universidade de Santiago de Compostela
MEDYCZNY W LUBLINIE, University of
Original Assignee
Universidade de Santiago de Compostela
MEDYCZNY W LUBLINIE, University of
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universidade de Santiago de Compostela, MEDYCZNY W LUBLINIE, University of filed Critical Universidade de Santiago de Compostela
Publication of ES2964230A1 publication Critical patent/ES2964230A1/es
Application granted granted Critical
Publication of ES2964230B2 publication Critical patent/ES2964230B2/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES202330969A 2022-12-01 2023-11-23 Derivados N-((9-cloro-3,4-dihidro-2H-benzo[b][1,4]dioxepin-7-il)metil)-2-(6-fluoro-1H-indol-3-il)etano-1-amina, su modo de obtencion y su utilizacion Active ES2964230B2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL443018A PL245768B1 (pl) 2022-12-01 2022-12-01 Pochodne N-((9-chloro-3,4-dihydro-2H-benzo[b][1,4]dioksepin-7-ylo)metylo)-2-(6-fluoro-1H-indol-3-ylo)etano-1-aminy, sposób ich wytwarzania i zastosowanie

Publications (2)

Publication Number Publication Date
ES2964230A1 ES2964230A1 (es) 2024-04-04
ES2964230B2 true ES2964230B2 (es) 2024-11-04

Family

ID=90526820

Family Applications (1)

Application Number Title Priority Date Filing Date
ES202330969A Active ES2964230B2 (es) 2022-12-01 2023-11-23 Derivados N-((9-cloro-3,4-dihidro-2H-benzo[b][1,4]dioxepin-7-il)metil)-2-(6-fluoro-1H-indol-3-il)etano-1-amina, su modo de obtencion y su utilizacion

Country Status (2)

Country Link
ES (1) ES2964230B2 (pl)
PL (1) PL245768B1 (pl)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA05006433A (es) * 2002-12-20 2005-08-19 Merck Patent Gmbh Benzodioxepinas sustituidas.

Also Published As

Publication number Publication date
ES2964230A1 (es) 2024-04-04
PL245768B1 (pl) 2024-10-07
PL443018A1 (pl) 2024-06-03

Similar Documents

Publication Publication Date Title
JPH07228558A (ja) スチルベン誘導体及びそれを含有する制癌剤
IE913732A1 (en) Oxindole peptide antagonists
US6699864B2 (en) Substituted phenyl-piperazine derivatives, their preparation and use
JPS61155358A (ja) ジアリール酪酸誘導体
JP7028780B2 (ja) ベンズアミド誘導体
JP2000505096A (ja) 抗腫瘍剤としてのアリールスルホニルイミダゾロン誘導体
CN105218621A (zh) 一类具有抗肿瘤活性的脱氢枞酸苯并咪唑席夫碱类杂环衍生物及其制备方法和应用
US20070037874A1 (en) Manufacturing process of isoflavan or isoflavene derivatives
ES2964230B2 (es) Derivados N-((9-cloro-3,4-dihidro-2H-benzo[b][1,4]dioxepin-7-il)metil)-2-(6-fluoro-1H-indol-3-il)etano-1-amina, su modo de obtencion y su utilizacion
JP4225894B2 (ja) 縮合環式基を有する環状ジアミン化合物
MXPA06002065A (es) Derivados de bencimidazolona y quinazolinona sustituidos con biciclo-3.1.1-heptano como agonistas en receptores orl1 humanos.
CN117800977B (zh) 一种2,3-稠合喹唑啉酮化合物的制备方法和应用
CN110981838B (zh) 5-亚胺-四氢呋喃基甲胺衍生物及其制备方法和应用
WO2023127291A1 (ja) デメチルノビレチンの製造方法
FR2702211A1 (fr) Nouveaux dérivés de la phénoxy-2 éthylamine, leur préparation et leur application en thérapeutique.
JP4745491B2 (ja) インドール長鎖アルコール及びこれを含有する医薬
CN115521317B (zh) 一种制备纳呋拉啡中间体的方法
EP1474390B1 (en) Indole derivatives substituted with long-chain alcohols and medicaments containing them
CN101830848B (zh) 一种多胺衍生物及其制备方法和应用
CN101759665A (zh) 取代苯基哌嗪芳烷醇衍生物及其在制备镇痛药物中的应用
Gangjee et al. Synthesis of a substituted tetrahydropyrimido [4, 5‐c][2, 7] naphthyridine as a tricyclic 5‐deaza nonclassical folate
CN108358898B (zh) 一种具有抗癌活性的对萘醌衍生物及其合成方法
JPWO2001062769A1 (ja) インドロピロロカルバゾール誘導体の製造法、その製造中間体及びその製造法
US20050107455A1 (en) Novel tricycloimidazoline derivatives method for production and use thereof as medicaments
CN118405988A (zh) 新型ferrostatin-1类似物、制备方法与应用

Legal Events

Date Code Title Description
BA2A Patent application published

Ref document number: 2964230

Country of ref document: ES

Kind code of ref document: A1

Effective date: 20240404

FG2A Definitive protection

Ref document number: 2964230

Country of ref document: ES

Kind code of ref document: B2

Effective date: 20241104